340 related articles for article (PubMed ID: 10636283)
41. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
Yue TL; Vickery-Clark L; Louden CS; Gu JL; Ma XL; Narayanan PK; Li X; Chen J; Storer B; Willette R; Gossett KA; Ohlstein EH
Circulation; 2000 Nov; 102(19 Suppl 3):III281-8. PubMed ID: 11082402
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.
Gallo R; Padurean A; Jayaraman T; Marx S; Roque M; Adelman S; Chesebro J; Fallon J; Fuster V; Marks A; Badimon JJ
Circulation; 1999 Apr; 99(16):2164-70. PubMed ID: 10217658
[TBL] [Abstract][Full Text] [Related]
43. A new rat model of small vessel stenting.
Indolfi C; Esposito G; Stabile E; Cavuto L; Pisani A; Coppola C; Torella D; Perrino C; Di Lorenzo E; Curcio A; Palombini L; Chiariello M
Basic Res Cardiol; 2000 Jun; 95(3):179-85. PubMed ID: 10879619
[TBL] [Abstract][Full Text] [Related]
44. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.
Tsihlis ND; Oustwani CS; Vavra AK; Jiang Q; Keefer LK; Kibbe MR
Cell Biochem Biophys; 2011 Jun; 60(1-2):89-97. PubMed ID: 21448667
[TBL] [Abstract][Full Text] [Related]
45. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
46. N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury.
Hayashi K; Takahata H; Kitagawa N; Kitange G; Kaminogo M; Shibata S
Neurol Res; 2001 Oct; 23(7):731-8. PubMed ID: 11680513
[TBL] [Abstract][Full Text] [Related]
47. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury.
Lee JS; Adrie C; Jacob HJ; Roberts JD; Zapol WM; Bloch KD
Circ Res; 1996 Feb; 78(2):337-42. PubMed ID: 8575078
[TBL] [Abstract][Full Text] [Related]
48. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
[TBL] [Abstract][Full Text] [Related]
49. Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model.
Kim DW; Park YS; Kim YG; Piao H; Kwon JS; Hwang KK; Youn TJ; Park JB; Yun YP; Sachinidis A; Kim CH; Cho MC; Ahn HY
Heart Vessels; 2004 Sep; 19(5):242-7. PubMed ID: 15372300
[TBL] [Abstract][Full Text] [Related]
50. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model.
Lee S; Lim HJ; Park HY; Lee KS; Park JH; Jang Y
Atherosclerosis; 2006 May; 186(1):29-37. PubMed ID: 16098530
[TBL] [Abstract][Full Text] [Related]
51. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.
Chen SJ; Chen YF; Miller DM; Li H; Oparil S
Circulation; 1994 Nov; 90(5):2468-73. PubMed ID: 7955204
[TBL] [Abstract][Full Text] [Related]
52. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
53. Simvastatin, a potent HMG-CoA reductase inhibitor, inhibits the proliferation of human and bovine endothelial cells in vitro.
Sato I; Ma L; Ikeda M; Morita I; Murota S
J Atheroscler Thromb; 1998; 4(3):102-6. PubMed ID: 9730140
[TBL] [Abstract][Full Text] [Related]
54. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis.
Sinnaeve P; Chiche JD; Gillijns H; Van Pelt N; Wirthlin D; Van De Werf F; Collen D; Bloch KD; Janssens S
Circulation; 2002 Jun; 105(24):2911-6. PubMed ID: 12070122
[TBL] [Abstract][Full Text] [Related]
56. Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration.
Pinkaew D; Cho SG; Hui DY; Wiktorowicz JE; Hutadilok-Towatana N; Mahabusarakam W; Tonganunt M; Stafford LJ; Phongdara A; Liu M; Fujise K
Biochim Biophys Acta; 2009 Jan; 1790(1):31-9. PubMed ID: 18930785
[TBL] [Abstract][Full Text] [Related]
57. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
[TBL] [Abstract][Full Text] [Related]
58. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
[TBL] [Abstract][Full Text] [Related]
59. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
Min KM; Park SW; Cho KY; Song MS; Kim DK; Park GS; Lee MK
Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo.
Ahn JD; Morishita R; Kaneda Y; Lee SJ; Kwon KY; Choi SY; Lee KU; Park JY; Moon IJ; Park JG; Yoshizumi M; Ouchi Y; Lee IK
Circ Res; 2002 Jun; 90(12):1325-32. PubMed ID: 12089071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
